asa glp 1 guidelines Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Perioperative management of patients taking

A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society explicitly states that restrictive eating disorder is a general contraindication to GLP-1 use and that individuals with a history of eating disorders should be referred to an eating disorders specialist before these medications are prescribed ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )

Coronary artery disease, alongside peripheral artery disease (PAD) and ischaemic strokes, is a manifestation of atherosclerosis, a process whereby arteries undergo gradual stiffening and stenosis due to the build-up of inflammatory, fibro-lipidic plaques in their subintimal compartment [3]

After taking individual risk factors into account, the risk for non-live birth was 29.7% with medication continuation versus 27.1% with non-continuation, a difference that was not deemed statistically significant

Insoluble fiber requires more caution

The effects of GLP-1RAs on endometrial and ovarian cancer risk Concerning ovarian cancer, current evidence suggests that GLP-1RAs are not associated with an increased risk of ovarian cancer [38]